Results 31 to 40 of about 634,130 (287)
Human Vaccines & Immunotherapeutics, 2023 Combined measles-mumps-rubella (MMR) vaccines produced by GSK (GSK-MMR) and Merck (Merck-MMR) have demonstrated effectiveness and an acceptable safety profile, as documented over decades of post-licensure use in various regions worldwide.
Md Ahsan Habib +4 more
doaj +1 more source
Efficacy of Rubella Vaccination after Co-Inoculation with Rhogam
Viruses, 2023 Congenital rubella syndrome is a constellation of birth defects that can have devastating consequences, impacting approximately 100,000 births worldwide each year. The incidence is much lower in countries that routinely vaccinate their population. In the
Joshua S. Brunton +5 more
doaj +1 more source
Mitigating Vaccine Hesitancy and Building Trust to Prevent Future Measles Outbreaks in England
Vaccines, 2023 Measles, a highly infectious respiratory viral infection associated with severe morbidity and mortality, is preventable when coverage with the highly effective measles, mumps and rubella vaccine (MMR) is ≥95%. Vaccine hesitancy is responsible for measles
Sarah Thompson +3 more
doaj +1 more source
Archives of Disease in Childhood, 2000 Live measles and mumps vaccine viruses are cultured in chick embryo fibroblasts and may contain minute amounts of egg related antigens.1-3 In view of this, there has been a longstanding debate on the safety of these vaccines in children with severe allergic reactions to egg. Initially it was believed that such children could safely receive the vaccine;
R, Lakshman, A, Finn
openaire +2 more sources
A novel cancer vaccine for melanoma based on an approved vaccine against measles, mumps, and rubella
Molecular Therapy: Oncolytics, 2022 Common vaccines for infectious diseases have been repurposed as cancer immunotherapies. The intratumoral administration of these repurposed vaccines can induce immune cell infiltration into the treated tumor. Here, we have used an approved trivalent live
Manlio Fusciello +10 more
doaj +1 more source
Vaccines, 2022 Cross-protection from previous live attenuated vaccines is proposed to explain the low impact of COVID-19 on children. This study aimed to evaluate the effect of live attenuated MMR vaccines on the risk of being hospitalized for COVID-19 in children.
Epiphane Kolla +5 more
doaj +1 more source
Analysis of Measles-Mumps-Rubella (MMR) Titers of Recovered COVID-19 Patients
mBio, 2020 The measles-mumps-rubella (MMR) vaccine has been theorized to provide protection against coronavirus disease 2019 (COVID-19). Our aim was to determine whether any MMR IgG titers are inversely correlated with severity in recovered COVID-19 patients ...
Jeffrey E. Gold +9 more
doaj +1 more source
Determination of ELISA reactive mumps IgG antibodies in MMR vaccine recipients in comparison with MMR vaccine naive children: A cross sectional study [PDF]
Scripta Medica, 2021 Background/Aim: Mumps is by vaccine preventable infectious disease characterised by parotitis. In India mumps vaccines are not currently used under National Immunisation Programme (NIP).
Gupta Riya, Saxena Naveen, Gupta Parul
doaj +1 more source
Vaccine message framing and parents' intent to immunize their infants for MMR [PDF]
, 2014 BACKGROUND AND OBJECTIVE: Emphasizing societal benefits of vaccines has been linked to increased vaccination intentions in adults. It is unclear if this pattern holds for parents deciding whether to vaccinate their children.
Downs, Stephen M. +5 more
core +1 more source
MMR vaccine---worries are not justified [PDF]
Archives of Disease in Childhood, 2001 The advocates of Vaccination have exalted in the prospect of exterminating the Small Pox from the face of the earth; while its opponents have framed their tales of horror, replete with stories of novel diseases and unheard-of plagues. ... When I consider the many evidences in favour of Vaccination, which the public documents of almost every nation ...
D A, Elliman, H E, Bedford
openaire +2 more sources